Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that ...
First Jointly Developed AI Agent Helps Customers Maximize Cisco Investments and Boosts Productivity News Summary: Powerful Partnership: The first of several AI agents being developed by Cisco with ...
Choose from Double Helix Logo stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...
If you want to kick back and meet or make friends — but coffee shops and the attendant caffeine rush, and bars serving ...
Researchers developed a pyrene coating for graphene membranes, addressing delamination and enhancing device performance in ...
Osaka University researchers developed an electrically controlled nanogate, enabling precise regulation of ion transport and ...
12h
News Medical on MSNTargeting PAK5 could offer new therapeutic approach for endometriosisEndometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...
Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...
43m
News Medical on MSNEMBL researchers reveal new structural insights into minor spliceosome functionIn human cells, only a small proportion of the information written in genes is used to produce proteins. How does the cell select this information? A large molecular machine called the spliceosome ...
The USAN designation reflects Okyo Pharma’s commitment to developing new therapies for unmet medical needs in ophthalmology. The suffix “-mod” in urcosimod denotes its classification as a modulator of ...
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results